[ORGANIZATION]
GLP‑1 receptor agonist
Featured in 1 tracked story · first seen
Situations
German obesity medication reimbursement debate
2 clusters · 3 sources · last updated
Latest: Germany obesity drug use rises amid health insurance cost concerns
Discussions regarding the reimbursement of GLP-1-based weight-loss medications in Germany have intensified. Sonja Optendrenk, chair of the Gemeinsamer Bundesausschuss (G-BA), suggested that statutory health insurance sho